News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
TempraMed Signs Exclusive Distribution Agreement with Leading Consumer Health Distributor in Israel
November 26, 2025
·
7 min read
Press Releases
Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update
November 26, 2025
·
3 min read
Press Releases
PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
November 26, 2025
·
4 min read
Press Releases
Optimi Health to Supply MDMA to MAPS Israel’s Clinical Trial for Trauma-Related PTSD
November 26, 2025
·
6 min read
Press Releases
MustGrow Announces Record Q3-2025 Results
November 25, 2025
·
1 min read
Press Releases
OS Therapies Receives Non-Proprietary Name ‘daznelimgene lisbac’ for OST-HER2 from World Health Organization
November 25, 2025
·
1 min read
Press Releases
Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762
November 25, 2025
·
1 min read
Press Releases
Skye Bioscience to Participate in Upcoming Investment Conferences
November 24, 2025
·
1 min read
Press Releases
NervGen Pharma Reports Third Quarter Financial Results and Provides Business Updates
November 24, 2025
·
13 min read
Press Releases
NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury
November 24, 2025
·
1 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us